DocDollars

Indivior Inc.

VA · United States · Reporting entity ID 100000136552

Total reported 2019–2025
$61.6M
#145 of 2,960 reporting companies — 0.1% of all reported industry payments
$10.9M in general payments across 121,110 records, plus $50.7M in research funding across 8,891 records.

How it breaks down

General payments $10,941,118
Research funding $50,681,691

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Indivior Inc. reported $61.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #145 of 2,960 reporting companies. 82% of that was research funding and 18% general payments such as consulting, speaking, food and travel. 121,110 general payment records and 8,891 research records were filed.

Common questions about Indivior Inc.

How much has Indivior Inc. paid US doctors?

Indivior Inc. reported $61,622,809 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $10,941,118 in general payments, $50,681,691 in research funding.

How does Indivior Inc. rank among drug and device companies?

It ranks #145 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Indivior Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.